According to information on the QCC app, Guangzhou Ruiling Pharmaceutical Co., Ltd. was recently established with a registered capital of 10 million yuan. Its business scope includes natural science research and experimental development; biological and chemical product technology research and development; medical research and experimental development; technology import and export; and import and export of goods. According to QCC's equity penetration display, the company is wholly-owned by Shanghai Ruihongdi Pharmaceutical Co., Ltd. The latter is jointly held by Hengrui Medicine and Jiangsu Hengrui Medicine Group Co., Ltd.
恒瑞医药等在广州成立医药新公司
Jiangsu Hengrui Pharmaceuticals and others have established a new pharmaceutical company in Guangzhou.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.